Back to Search
Start Over
XAF1 prevents hyperproduction of type I interferon upon viral infection by targeting IRF7.
- Source :
-
EMBO reports [EMBO Rep] 2023 Jan 09; Vol. 24 (1), pp. e55387. Date of Electronic Publication: 2022 Nov 17. - Publication Year :
- 2023
-
Abstract
- Interferon regulatory factor (IRF) 3 and IRF7 are master regulators of type I interferon (IFN-I)-dependent antiviral innate immunity. Upon viral infection, a positive feedback loop is formed, wherein IRF7 promotes further induction of IFN-I in the later stage. Thus, it is critical to maintain a suitably low level of IRF7 to avoid the hyperproduction of IFN-I. In this study, we find that early expression of IFN-I-dependent STAT1 promotes the expression of XAF1 and that XAF1 is associated specifically with IRF7 and inhibits the activity of XIAP. XAF1-knockout and XIAP-transgenic mice display resistance to viral infection, and this resistance is accompanied by increases in IFN-I production and IRF7 stability. Mechanistically, we find that the XAF1-XIAP axis controls the activity of KLHL22, an adaptor of the BTB-CUL3-RBX1 E3 ligase complex through a ubiquitin-dependent pathway. CUL3-KLHL22 directly targets IRF7 and catalyzes its K48-linked ubiquitination and proteasomal degradation. These findings reveal unexpected functions of the XAF1-XIAP axis and KLHL22 in the regulation of IRF7 stability and highlight an important target for antiviral innate immunity.<br /> (© 2022 The Authors.)
Details
- Language :
- English
- ISSN :
- 1469-3178
- Volume :
- 24
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- EMBO reports
- Publication Type :
- Academic Journal
- Accession number :
- 36394357
- Full Text :
- https://doi.org/10.15252/embr.202255387